Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, December 2, 2022
[ Fri, Dec 02nd 2022
] - WOPRAI
[ Fri, Dec 02nd 2022
] - WOPRAI
[ Fri, Dec 02nd 2022
] - WOPRAI
[ Fri, Dec 02nd 2022
] - WOPRAI
[ Fri, Dec 02nd 2022
] - WOPRAI
[ Fri, Dec 02nd 2022
] - WOPRAI
[ Fri, Dec 02nd 2022
] - WOPRAI
[ Fri, Dec 02nd 2022
] - WOPRAI
[ Fri, Dec 02nd 2022
] - WOPRAI
[ Fri, Dec 02nd 2022
] - WOPRAI
[ Fri, Dec 02nd 2022
] - WOPRAI
[ Fri, Dec 02nd 2022
] - WOPRAI
[ Fri, Dec 02nd 2022
] - WOPRAI
[ Fri, Dec 02nd 2022
] - WOPRAI
[ Fri, Dec 02nd 2022
] - WOPRAI
[ Fri, Dec 02nd 2022
] - WOPRAI
[ Fri, Dec 02nd 2022
] - WOPRAI
[ Fri, Dec 02nd 2022
] - WOPRAI
[ Fri, Dec 02nd 2022
] - WOPRAI
[ Fri, Dec 02nd 2022
] - WOPRAI
[ Fri, Dec 02nd 2022
] - WOPRAI
Thu, December 1, 2022
[ Thu, Dec 01st 2022
] - WOPRAI
[ Thu, Dec 01st 2022
] - WOPRAI
[ Thu, Dec 01st 2022
] - WOPRAI
[ Thu, Dec 01st 2022
] - WOPRAI
[ Thu, Dec 01st 2022
] - WOPRAI
[ Thu, Dec 01st 2022
] - WOPRAI
[ Thu, Dec 01st 2022
] - WOPRAI
[ Thu, Dec 01st 2022
] - WOPRAI
Tessa Romero Maintained (AGIO) at Hold with Decreased Target to $33 on, Dec 1st, 2022
Tessa Romero of JP Morgan, Maintained "Agios Pharmaceuticals, Inc." (AGIO) at Hold with Decreased Target from $48 to $33 on, Dec 1st, 2022.
Tessa has made no other calls on AGIO in the last 4 months.
There are 2 other peers that have a rating on AGIO. Out of the 2 peers that are also analyzing AGIO, 1 agrees with Tessa's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Salveen Richter of "Goldman Sachs" Upgraded from Strong Sell to Hold and Increased Target to $32 on, Thursday, November 17th, 2022
This is the rating of the analyst that currently disagrees with Tessa
- Andrew Berens of "SVB Leerink" Maintained at Buy with Increased Target to $37 on, Friday, August 5th, 2022
